Bloomin' Brands Inc. Common Stock (BLMN)
Fast GrowerFairStock Score: 45/100 — MIXED
Key Financials
| Current Price | $8.04 |
| Market Cap | $549M |
| P/E Ratio | 33.5 |
| ROE | 6.82% |
| Dividend Yield | 8.25% |
| Sector | Consumer Cyclical |
Strengths
- Generates $20 million in annual free cash flow (3.7% yield on market cap)
- Revenue growth of 63.2% demonstrates strong top-line momentum
- Attractive 9.1% dividend yield providing steady income returns
- Established organization with 64,000 employees providing operational scale
Concerns
- Trades significantly above Graham Number ($3) with negative 117% margin of safety—limited downside protection
- High leverage at 6.00x debt-to-equity increases financial risk and interest expense burden
- Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
- Altman Z-Score of -0.2 places it in the financial distress zone—elevated bankruptcy risk
AI Analysis
Bloomin' Brands Inc. Common Stock is a micro-cap consumer cyclical company valued at $549 million. Revenue stands at $4.0 billion, though the company is currently unprofitable. From a quality standpoint, Bloomin' shows solid Piotroski F-Score of 6/9 and distressed Altman Z-Score of -0.2 warrants caution. On valuation, the stock is commanding a steep 63.9x multiple, with trades far above its Graham Number ($3) with no margin of safety. Growth dynamics show revenue growing at 63.2% and profit growth of 83.0%. The 9.1% dividend yield adds an income component for patient holders. Our composite FairStock Score of 45/100 reflects mixed fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.
Bull Case
Bloomin''s 63% revenue growth trajectory could accelerate as it captures additional market share in the consumer cyclical sector. With $20 million in annual free cash flow (3.7% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
At 64x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer